Tissue engineering skeletal muscle for orthopaedic applications

Clinical Orthopaedics and Related Research

Volumn 403, Issue SUPPL., 2002, Pages

  Payumo, Francis C ^a   Kim, Hyun D ^a   Sherling, Michael A ^a   Smith, Lee P ^a   Powell, Courtney ^a   Wang, Xiao ^a   Keeping, Hugh S ^a   Valentini, Robert F ^a   Vandenburgh, Herman H ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 6; ERYTHROPOIETIN; GROWTH HORMONE; PROTEIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT BONE MORPHOGENETIC PROTEIN 6; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

BIOARTIFICIAL ORGAN; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CONFERENCE PAPER; ENZYME ACTIVITY; GENETIC TRANSDUCTION; IMMUNOHISTOCHEMISTRY; MESENCHYME; MYOBLAST; OSSIFICATION; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STAINING; TISSUE ENGINEERING; TRANSGENE; WESTERN BLOTTING;

EID: 0036810048     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200210001-00027     Document Type: Conference Paper

References (50)

1. Ahrens M, Ankenbauer T, Schröder D, et al: Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 12:871-880, 1993.
2. Aronow MA, Gerstenfeld LC, Owen TA, et al: Factors that promote progressive development of osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol 143:213-221, 1990.
3. Aubin JE, Turksen K, Heersche JNM: Osteoblastic cell lineage. In Noda M (ed). Cellular and Molecular Biology of Bone. Boston, Academic Press 1-45, 1993.
4. Bessey OA, Lowry, OH, Brock MJ: A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J Biol Chem 164:321-329, 1946.
5. Blau HM, Springer ML: Gene therapy: A novel form of drug delivery. N Engl J Med 333:1204-1207, 1995.
6. Boden SD, McCuaig, Hair G, et al: Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. Endocrinology 137:3401-3407, 1996.
7. Bonham L, Palmer T, Miller AD: Prolonged expression of therapeutic levels of human granulocyte colony-stimulating factor in rats following gene transfer to skeletal muscle. Human Gene Ther 7:1423-1429, 1996.
8. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162:156-159, 1987.
9. Drozdoff V, Wall NA, Pledger, WJ: Expression and growth inhibitory effect of decapentaplegic Vg-related protein-6: Evidence for a regulatory role in keratinocyte differentiation. Proc Natl Acad Sci USA 91:5528-5532, 1994.
10. Florini JR, Ewton DZ, Coolican SA: Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17:481-517, 1996.
11. Gitelman SE, Kirk M, Ye JQ, et al: Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells. Cell Growth Differentiation 6:827-836, 1995.
12. Glansbeek HL, van Beuningen HM, Vitters EL, et al: Bone morphogenetic protein 2 stimulates articular cartilage proteoglycan synthesis in vivo but does not counteract interleukin-1a effects of proteoglycan synthesis and content. Arthritis Rheum 40:1020-1028, 1996.
13. Grgic M, Jelic M, Basic B, et al: Regeneration of articular cartilage defects in rabbits by osteogenic protein-1 (bone morphogenetic protein-7). Acta Med Croatica 51:23-27, 1997.
14. Harris H: The human alkaline phosphatases: What we know and what we don't know. Clin Chimica Acta 186:133-150, 1989.
15. Hughes FJ, Collyer J, Stanfield M, et al: The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 136:2671-2677, 1995.
16. Katagiri T, Yamaguchi A, Ikeda T, et al: The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 172:295-299, 1990.
17. Katagiri T, Yamaguchi A, Komaki M, et al: Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into osteoblast lineage. J Cell Biol 127:1755-1766, 1994.
18. Kingsley DM: The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146, 1994.
19. Lee PHU, Wang XY, and Vandenburgh HH: Longterm in vivo delivery of recombinant human insulin-like growth factor-1 by tissue engineered skeletal muscle implants for treating disuse muscle atrophy in mice. Grav Space Biol Bull 14:17, 2000. Abstract.
20. Lu Y, Shansky J, Del Tatto M, et al: Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis. Circulation 104:594-599, 2001.
21. McMahon DK, Anderson PAW, Nassar R, et al: C2C12 cells: Biophysical, biochemical, and immunocytochemical properties. Am J Physiol Cell Physiol 266:C1795-C1802, 1994.
22. Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980-990, 1989.
23. Murray SS, Murray EJB, Glackin CA et al: Bone morphogenetic protein inhibits differentiation and affects expression of helix-loop-helix regulatory molecules in myoblastic cells. J Cell Biochem 53:51-60, 1993.
24. National Institutes of Health: Guide for the Care and Use of Laboratory Animals. Publication Number 85-23. Bethesda, National Institutes of Health 1985.
25. Payumo FC, Kim H, Sherling M, et al: Expression of recombinant human bone morphogenetic protein-6 in C2C12 myoblasts. Artif Organs 21:496, 1997. Abstract.
26. Powell C, Shansky J, DelTatto M, et al: Tissue engineered human bioartificial muscles expressing a foreign recombinant protein for gene therapy. Human Gene Ther 10:565-577, 1999.
27. Powell C, Shansky J, Del Tatto M, Vandenburgh HH: Bioartificial muscles in gene therapy. In Morgan JR (ed). Gene Therapy Protocols. Ed 2. Totowa, NJ, Humana Press, Inc 219-231, 2002.
28. Powell C, Smiley B, Mills J, Vandenburgh H: Mechanical stimulation of tissue engineered human skeletal muscle. Am J Physiol Cell Physiol 2002. In press.
29. Reddi AH: Symbiosis of biotechnology and biomaterials: Applications in tissue engineering of bone and cartilage. J Cellular Biochem 56:192-195, 1994.
30. Reddi AH, Anderson WA: Collagenous bone matrix-induced endochondral ossification and hemopoiesis. J Cell Biol 69:557-572, 1976.
31. Shansky J, Del Tatto M, Vandenburgh HH: Reversible long-term delivery of erythropoietin from a tissue engineered bioartificial muscle (BAM). Keystone Symposia on Molecular Cellular Biology, and Gene Therapy 41, 1999 Abstract.
32. Sprague SM, Krieger NS, Bushinsky DA: Aluminum inhibits bone nodule formation and calcification in vitro. Am J Physiol 264:F882-F890, 1993.
33. Springer ML, Blau HM: High-efficiency retroviral infection of primary myoblasts. Somat Cell Mol Genet 23:203-209, 1997.
34. Tomizawa K, Matsui H, Kondo E, et al: Developmental alteration and neuron-specific expression of bone morphogenetic protein-6 (BMP-6) mRNA in rodent brain. Brain Res Mol Brain Res 28:122-128, 1995.
35. Urist MR: Bone: Formation by autoinduction. Science 150:893-899, 1965.
36. Urist MR: Bone morphogenetic protein, bone regeneration, heterotrophic ossification and the bone-bone marrow consortium. In Peck WA (ed). Bone and Mineral Research. Vol 6. New York, Elsevier Science Publishers BV 57-112, 1989.
37. Vandenburgh H, Del Tatto M, Shansky J et al: Attenuation of skeletal muscle wasting with recombinant human growth hormone secreted from a tissueengineered bioartificial muscle. Human Gene Ther 9:2555-2564, 1998.
38. Vandenburgh HH, Del Tatto M, Shansky J, et al: Tissue engineered skeletal muscle organoids for reversible gene therapy. Human Gene Ther 7:2195-2200, 1996.
39. Vandenburgh HH, Shansky J, Del Tatto M, Chromiak J: Organogenesis of skeletal muscle in tissue culture. In Morgan J, Yarmush M (eds). Methods in Molecular Medicine: Tissue Engineering. Totowa, NJ, Humana Press 205-217, 1999.
40. Vandenburgh HH, Solerssi R, Shansky J, et al: Response of neonatal rat cardiomyocytes to repetitive mechanical stimulation in vitro. Ann NY Acad Sci 752:19-29, 1995.
41. Volek-Smith H, Urist MR: Recombinant human bone morphogenetic protein (rhBMP) induced heterotropic bone development in vivo and in vitro. Proc Soc Exp Biol Med 211:265-272, 1996.
42. Wade R, Kedes L: Developmental regulation of contractile protein genes. Ann Rev Physiol 51:179-188, 1989.
43. Wall NA, Blessing M, Wright CVE, et al: Biosynthesis and in vivo localization of the decapentaplegic-Vg-related protein. DVR-6 (Bone morphogenetic protein-6). J Cell Biol 120:493-502, 1993.
44. Wang EA, Rosen V, D'Alessandro J, et al: Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87:2220-2224, 1990.
45. Wozney JM: The bone morphogenetic protein family and osteogenesis. Mol Reprod Devel 32:160-167, 1992.
46. Wozney JM: Bone morphogenetic proteins and their gene expression. In Noda M (ed). Cellular and Molecular Biology of Bone. Boston, Academic Press 131-167, 1993.
47. Wozney JM, Rosen V: Bone Morphogenetic Proteins. In Mundy GR, Martin TJ (eds). Handbook of Experimental Pharmacology/Physiology and Pharmacology of Bone. Vol 107. Berlin, Springer-Verlag 725-748, 1993.
48. Yamaguchi A: Regulation of differentiation pathway of skeletal mesenchymal cells in cell lines by transforming growth factor-β superfamily. Semin Cell Biol 6:165-173, 1995.
49. Yamaguchi A, Ishizuya T, Kintou N, et al: Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Comm 220:366-371, 1996.
50. Yamaguchi A, Katagiri T, Ikeda T, et al: Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113:681-687, 1991.